| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| Revenue | $445.7M | +12.9% |
| Cost of Revenue | $304.5M | +32.2% |
| Gross Profit | $141.2M | -14.2% |
| R&D Expense | $54.7M | +1.7% |
| SG&A Expense | $96.4M | +42.9% |
| Operating Income | -$9.9M | -122.8% |
| Pre-tax Income | -$13.3M | -155.5% |
| Income Tax | -$10.4M | -2023.7% |
| Net Income | -$4.2M |
| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $77.2M | -48.1% |
| Short-term Investments | $24.7M | -22.7% |
| Accounts Receivable | $60.2M | -4.0% |
| Inventory | $90.6M | +26.5% |
| Current Assets | $368.9M | -8.1% |
| Total Assets | $914.2M | -1.5% |
| Current Liabilities | $101.4M | +5.4% |
| Line Item | 2022-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.6M | -111.1% |
| Capital Expenditures | $22.3M | +97.9% |
| Investing Cash Flow | -$52.3M | +86.2% |
| Financing Cash Flow | -$16.6M | -108.6% |
| Free Cash Flow | -$31.9M | -142.4% |
| -117.9% |
| EPS (Basic) | -$0.17 | -117.5% |
| EPS (Diluted) | -$0.17 | -117.7% |
| Long-term Debt |
| $190.0M |
| -5.0% |
| Stockholders' Equity | $608.0M | -0.7% |